Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Three related series of antitumor tyrosine kinase inhibitors patented by Merck

March 18, 2003

Results from European phase III trial of Plenaxis discussed at EAU meeting

March 17, 2003

Maxim receives NCI SBIR grant for MX-2167

March 17, 2003

NCI grant for trial of NCX-4016 in prevention of colon cancer

March 17, 2003

Novel HDAC inhibitors in Roche development pipeline

March 17, 2003

Bryostatin-1 increases survival in advanced renal cell carcinoma

March 17, 2003

New antiinflammatory IKK-2 inhibitors in early development at AstraZeneca

March 17, 2003

Teva invests in Gamida-Cell

March 14, 2003

OSI to market Novantrone in oncology indications

March 14, 2003

Lorus allowed U.S. patent that protects key antisense target

March 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...